{'52WeekChange': None,
 'SandP52WeekChange': None,
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 73.4,
 'askSize': 1100,
 'averageDailyVolume10Day': 299787,
 'averageVolume': 337046,
 'averageVolume10days': 299787,
 'beta': None,
 'beta3Year': 2.08,
 'bid': 71,
 'bidSize': 800,
 'bookValue': None,
 'category': 'Trading--Leveraged Equity',
 'circulatingSupply': None,
 'companyOfficers': [],
 'currency': 'USD',
 'dayHigh': 73.82,
 'dayLow': 70.631,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': None,
 'enterpriseValue': None,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 73.02857,
 'fiftyTwoWeekHigh': 83.06,
 'fiftyTwoWeekLow': 35.49,
 'fiveYearAverageReturn': -0.039100002,
 'fiveYearAvgDividendYield': None,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fundFamily': 'ProShares',
 'fundInceptionDate': 1270512000,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': None,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': 'Exchange Traded Fund',
 'logo_url': '',
 'longBusinessSummary': 'The investment seeks daily investment results that '
                        'correspond to two times (2x) the daily performance of '
                        'the Nasdaq Biotechnology IndexÂ®.\n'
                        ' The fund invests in financial instruments that '
                        'ProShare Advisors believes, in combination, should '
                        'produce daily returns consistent with the fund&#39;s '
                        'investment objective. The index is a modified '
                        'capitalization weighted index that includes '
                        'securities of Nasdaq listed companies that are '
                        'classified as either biotechnology or pharmaceutical. '
                        'The fund is non-diversified.',
 'longName': 'ProShares Ultra Nasdaq Biotechnology',
 'market': 'us_market',
 'marketCap': None,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_100661718',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': None,
 'navPrice': 75.18,
 'netIncomeToCommon': None,
 'nextFiscalYearEnd': None,
 'open': 73.82,
 'openInterest': None,
 'payoutRatio': None,
 'pegRatio': None,
 'phone': '866-776-5125',
 'previousClose': 75.0763,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': None,
 'quoteType': 'ETF',
 'regularMarketDayHigh': 73.82,
 'regularMarketDayLow': 70.631,
 'regularMarketOpen': 73.82,
 'regularMarketPreviousClose': 75.0763,
 'regularMarketPrice': 73.82,
 'regularMarketVolume': 335625,
 'revenueQuarterlyGrowth': None,
 'shortName': 'ProShares Ultra Nasdaq Biotechn',
 'startDate': None,
 'strikePrice': None,
 'symbol': 'BIB',
 'threeYearAverageReturn': 0.121300004,
 'totalAssets': 214214784,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': None,
 'twoHundredDayAverage': 61.845108,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '19ba15b8-982d-3c20-956f-11e842b6db91',
 'volume': 335625,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'yield': 0,
 'ytdReturn': None}